[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FI902316A0 - Förfarande för framställning av terapeutiskt verkande substituerade dihydropyrrolizinföreningar - Google Patents

Förfarande för framställning av terapeutiskt verkande substituerade dihydropyrrolizinföreningar

Info

Publication number
FI902316A0
FI902316A0 FI902316A FI902316A FI902316A0 FI 902316 A0 FI902316 A0 FI 902316A0 FI 902316 A FI902316 A FI 902316A FI 902316 A FI902316 A FI 902316A FI 902316 A0 FI902316 A0 FI 902316A0
Authority
FI
Finland
Prior art keywords
dihydropyrrolizine
therapeutically
substituted
compounds
preparation
Prior art date
Application number
FI902316A
Other languages
English (en)
Finnish (fi)
Other versions
FI95258B (sv
FI95258C (sv
Inventor
Gerd Dannhardt
Ludwig Steindl
Matthias Lehr
Original Assignee
Danhardt Gerd
Merckle Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danhardt Gerd, Merckle Gmbh filed Critical Danhardt Gerd
Publication of FI902316A0 publication Critical patent/FI902316A0/sv
Publication of FI95258B publication Critical patent/FI95258B/sv
Application granted granted Critical
Publication of FI95258C publication Critical patent/FI95258C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/323—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to the ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/337—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI902316A 1989-05-11 1990-05-09 Förfarande för framställning av terapeutiskt verkande substituerade dihydropyrrolizinföreningar FI95258C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3915450A DE3915450A1 (de) 1989-05-11 1989-05-11 Substituierte pyrrolverbindungen und deren anwendung in der pharmazie
DE3915450 1989-05-11

Publications (3)

Publication Number Publication Date
FI902316A0 true FI902316A0 (sv) 1990-05-09
FI95258B FI95258B (sv) 1995-09-29
FI95258C FI95258C (sv) 1996-01-10

Family

ID=6380477

Family Applications (1)

Application Number Title Priority Date Filing Date
FI902316A FI95258C (sv) 1989-05-11 1990-05-09 Förfarande för framställning av terapeutiskt verkande substituerade dihydropyrrolizinföreningar

Country Status (13)

Country Link
EP (1) EP0397175B1 (sv)
JP (1) JP2796876B2 (sv)
KR (1) KR0173455B1 (sv)
AR (1) AR246256A1 (sv)
AT (1) ATE98246T1 (sv)
AU (1) AU637098B2 (sv)
CA (1) CA2016501C (sv)
DD (1) DD294260A5 (sv)
DE (2) DE3915450A1 (sv)
DK (1) DK0397175T3 (sv)
ES (1) ES2062160T3 (sv)
FI (1) FI95258C (sv)
NO (1) NO174892C (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6492413B2 (en) 1993-01-15 2002-12-10 G.D. Searle & Co. 3.4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
EP0679157B1 (en) * 1993-01-15 1997-11-19 G.D. Searle & Co. Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
DE4338770A1 (de) * 1993-11-12 1995-05-18 Matthias Dr Lehr Indol-2-alkansäuren und ihre Derivate als Hemmstoffe der Phospholipase A¶2¶
DE4419315A1 (de) * 1994-06-01 1995-12-07 Merckle Gmbh Heteropyrrolizinverbindungen und deren Anwendung in der Pharmazie
DE4419246A1 (de) * 1994-06-01 1995-12-07 Merckle Gmbh Heteroarylsubstituierte Pyrrolizinverbindungen und deren Anwendung in der Pharmazie
DE4419247A1 (de) * 1994-06-01 1995-12-07 Merckle Gmbh Sulfonylierte Pyrrolizincarbonsäureamide und deren Anwendung in der Pharmazie
ATE255090T1 (de) * 1996-08-01 2003-12-15 Merckle Gmbh Acylpyrroldicarbonsäuren und acylindoldicarbonsäuren sowie ihre derivate als hemmstoffe der cytosolischen phospholipase a2
KR100749222B1 (ko) * 2000-01-28 2007-08-13 메르클레 게엠베하 6-(4-클로로페닐)-2,2-디메틸-7-페닐-2,3-디히드로-1ｈ-피롤리진-5-일아세트산의 제조 방법
DE10004157A1 (de) * 2000-02-01 2001-08-02 Merckle Gmbh Chem Pharm Fabrik 4-Pyridyl-und 2,4-Pyrimidinyl-substituierte Pyrrolderivate und ihre Anwendung in der Pharmazie
KR20020007836A (ko) * 2000-07-19 2002-01-29 신덕호 골프공
DE10141285A1 (de) 2001-08-23 2003-03-27 Merckle Gmbh Verfahren zur Herstellung von 6-(4-Chlorphenyl)-2,2-dimethyl-7-phnyl-2,3-dihydro-1H-pyrrolizin-5-yl-essigsäure
DE102005012971A1 (de) 2005-03-21 2006-09-28 Merckle Gmbh Polymorphe Form von 6-(4-Chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-essigsäure

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1156485A (en) * 1965-04-30 1969-06-25 Firmenich & Cie Thiazole Flavouring Agents
AU429651B2 (en) * 1968-08-08 1972-11-01 Commonwealth Scientific And Industrial Research Organization Antiviral 6, 7 dihydro 5h pyrrolizines and related compounds
DE2062984A1 (en) * 1970-12-21 1972-06-22 Messerschmitt, Thilo, 8094 Reitmehring; Dobeneck, Henning von, 8021 Icking 2-unsubstd-5-formyl-pyrrole prepn - by catalytic hydrogenation of 2-halo-5-formyl-pyrroles
DE2261965A1 (de) * 1971-12-23 1973-06-28 Continental Pharma Derivate der pyrrolessigsaeure und deren salze sowie von pyrrolacetonitril, verfahren zur herstellung dieser verbindungen, diese verbindungen enthaltende pharmazeutische produkte und verwendung dieser verbindungen und produkte
JPS5217074B2 (sv) * 1972-04-25 1977-05-13
JPS6011899B2 (ja) * 1978-12-27 1985-03-28 財団法人相模中央化学研究所 ピロ−ル酢酸誘導体の製造方法
JPS5687558A (en) * 1979-11-27 1981-07-16 Mcneilab Inc Manufacture of pyrrolee22acetic acids
US4284562A (en) * 1979-11-27 1981-08-18 Mcneilab, Inc. Process for preparing pyrrole-2-acetic acids
JPS56100784A (en) * 1980-01-16 1981-08-12 Yoshitomi Pharmaceut Ind Ltd Indolizine derivative
US4327221A (en) * 1980-10-15 1982-04-27 American Home Products Corporation 2-Substituted-3-hydroxythiazolo(2,3-8)-thiazolium salts and mesoionic didehydro derivatives thereof
WO1982002044A1 (en) * 1980-12-15 1982-06-24 Corp Ethyl Preparation of pyrrole esters
EP0091181B1 (en) * 1982-02-25 1986-12-17 Beecham Group Plc Aroyl pyrrolizine compounds, process for their preparation and pharmaceutical compositions containing them
FR2539417A1 (fr) * 1983-01-13 1984-07-20 Rhone Poulenc Sante Nouveaux pyrrolo-1, 2 heterocycles, leur preparation et les medicaments qui les contiennent
FR2557111B1 (fr) * 1983-12-21 1986-04-11 Rhone Poulenc Sante Nouveaux derives ortho-condenses du pyrrole, leur preparation et les medicaments qui les contiennent
IL78834A (en) * 1985-05-23 1992-07-15 Smithkline Beckman Corp 2,3-dihydro-5-(1,4-dihydropyridin-4-yl)-6-phenylimidazo(2,1-b)thiazoles and 6,7-dihydro-3-(1,4-dihydropyridin-4-yl)-2-phenyl-5h-imidazo(2,1-b)(1,3)thiazines and their use as intermediates in a process for preparing the corresponding pyridyl-substituted imidazo(2,1-b)thiazoles and 5h-imidazo(2,1-b)(1,3)thiazines
FR2601016B1 (fr) * 1986-07-04 1988-10-07 Rhone Poulenc Sante Nouveaux derives du 1h,3h-pyrrolo (1,2-c) thiazole, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2617484B1 (fr) * 1987-07-02 1989-10-20 Rhone Poulenc Sante Procede de preparation de l'acide (pyridyl-3)-3 1h-3h-pyrrolo (1,2-c) thiazolecarboxylique-7 dextrogyre

Also Published As

Publication number Publication date
EP0397175B1 (de) 1993-12-08
ES2062160T3 (es) 1994-12-16
JPH035455A (ja) 1991-01-11
NO174892C (no) 1994-07-27
DK0397175T3 (da) 1994-02-14
AU5480090A (en) 1990-11-15
NO174892B (no) 1994-04-18
DD294260A5 (de) 1991-09-26
AR246256A1 (es) 1994-07-29
FI95258B (sv) 1995-09-29
JP2796876B2 (ja) 1998-09-10
DE59003753D1 (de) 1994-01-20
EP0397175A1 (de) 1990-11-14
AU637098B2 (en) 1993-05-20
ATE98246T1 (de) 1993-12-15
NO902084L (no) 1990-11-12
KR0173455B1 (ko) 1999-02-01
CA2016501C (en) 2001-10-09
NO902084D0 (no) 1990-05-10
FI95258C (sv) 1996-01-10
CA2016501A1 (en) 1990-11-11
DE3915450A1 (de) 1990-11-15
KR900018103A (ko) 1990-12-20

Similar Documents

Publication Publication Date Title
NO177299C (no) Analogifremgangsmåte for fremstilling av aromatiske aminforbindelser
FI882007A (sv) Förfarande för framställning av inhibitorer för steroid-5- -reduktas
FI945441A (sv) Nytt förfarande för framställning av 7beta-substituerad-4-aza-5alfa-androstan-3-oner
FI892058A0 (sv) Förfarande för framställning av fenol
FI103666B1 (sv) Förfarande för framställning av bifenylderivat
FI952585A0 (sv) Förfarande för framställning av bensopyranföreningar
FI104171B (sv) Förfarande för framställning av mono-N-alkylerade polyazamakrocykliska föreningar
FI881303A0 (sv) Förfarande för framställning av ibuprofen
FI902316A0 (sv) Förfarande för framställning av terapeutiskt verkande substituerade dihydropyrrolizinföreningar
FI102270B1 (sv) Förfarande för framställning av dietrar
FI93119B (sv) Förfarande för framställning av nya tieno-triazolo-diatzepiner
FI98461B (sv) Förfarande för framställning av terapeutiskt användbara föreningar
IS3589A7 (is) Aðferð við framleiðslu á efnasambandinu Indenoindoles I
FI911701A (sv) Förfarande för framställning av terapeutiskt användbara 2-substituerade-3-karboxikarbapenemer
FI901606A0 (sv) Förfarande för framställning av sulfonylderivat av tieno-trizolo-diazepiner
FI892144A0 (sv) Förfarande för framställning av 5-C-hydroximetylaldohexosbaserade föreningar
NO180675C (no) Fremgangsmåte for fremstilling av aromatiske forbindelser
NO173871C (no) Fremgangsmaate for fremstilling av penemforbindelser
FI903604A0 (sv) Nytt förfarande för framställning av 2-diazo-3-trisubstituerade silyloxi-3-butenoater
FI102841B1 (sv) Förfarande för framställning av mannitol
NO174196C (no) Fremgangsmåte for fremstilling av omega-decenol
FI102370B1 (sv) Förfarande för framställnig av N-metyl-3,4-dimetoxifenyletylamin
FI901604A0 (sv) Förfarande för framställning av tieno-triazolo-diazepiner
NO940861D0 (no) Fremgangsmåte for fremstilling av substituerte 2-aminoteraliner
FI102166B1 (sv) Förfarande för framställning av N,N-dimetylaminometylarylföreningar

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: DANNHARDT, GERD

Owner name: MERCKLE GMBH